University of Illinois at Chicago

Chicago neighborhoods with barriers to social distancing had higher COVID-19 death rates

Neighborhood characteristics include low internet access, health insurance

Newswise — New research has found that Chicago neighborhoods with barriers to social distancing, including limited access to broadband internet and low rates of health insurance, had more COVID-19 deaths in spring 2020. The study, led by researchers at the University of Illinois Chicago, is published in the Annals of Epidemiology.

“We wanted to look at neighborhood characteristics that may contribute to higher death rates in certain neighborhoods in Chicago,” said Molly Scannell Bryan, a research assistant professor at the UIC Institute for Minority Health Research and corresponding author on the paper. “We originally expected that air quality and use of public transportation would be drivers, but we found that heightened barriers to being able to social distance, such as low or lack of internet access, was a more significant driver of COVID-19-related deaths, possibly through a higher risk of infection in those without internet access.”

COVID-19 is the illness caused by the SARS-CoV-2 virus, which emerged in fall 2019 and declared a pandemic by the World Health Organization in March 2020. In the United States, over 270,000 Americans have died of the disease.

The researchers sought to identify patterns in the census tracts with high rates of COVID-19 mortality in Chicago during the spring and early summer of 2020.  

They looked at 33 neighborhood characteristics for each census-tract. Chicago has almost 1,000 census tracts, each with approximately 4,000 people.

Neighborhood descriptors were obtained from the U.S. Census Bureau’s American Community Survey and information on COVID-19 deaths was obtained from the Office of the Medical Examiner of Cook County. Highly localized estimates of air quality, including nitrogen dioxide, ozone and very fine particulate matter, were obtained from colleagues at Northwestern University.  

Between March 16 and July 22, 2,514 COVID-19 deaths were recorded in Chicago.

The data revealed that COVID-19 death rates in Chicago showed similar racial disparities to those seen nationwide. Although non-Hispanic Black residents comprise 31% of Chicago’s population, they accounted for 42% of the COVID-19 deaths. Deaths among Hispanic/Latino residents occurred at a younger age — 63 years, compared with 71 for white residents.

After focusing on deaths that occurred outside of nursing homes, the researchers found that higher COVID-19 mortality was seen in neighborhoods with heightened barriers to social distancing and low health insurance coverage. Neighborhoods with a higher percentage of white and Asian residents had lower COVID-19 mortality. Mortality among white residents was highest in neighborhoods with lower educational attainment and a higher percentage of Hispanic/Latino residents. Among whites, mortality was lower in neighborhoods with a higher percentage of white or Asian residents.

“Barriers to social distancing really jumped out as a major driver of mortality, likely through increased risk of infection,” Scannell Bryan said. “Neighborhoods where residents do not have internet at home means residents are more likely to need to leave the house more often and come into contact with more people outside the home. In the spring, when there were such high levels of community spread, this would have put those people at higher risk.”

The researchers also found that while the overall death rate was higher among Black residents, no neighborhood characteristics were associated with COVID-19 death rates among Black residents specifically. In contrast, among white residents, neighborhood characteristics seemed to matter.

“We saw that white residents who died clustered in neighborhoods with higher levels of social vulnerability, whereas Black and Hispanic/Latino residents who died lived in neighborhoods with both high and low levels of social vulnerability.

“Our study revealed several neighborhood characteristics that are linked to higher COVID-19 death rates and these are the places that might benefit from additional testing and resources to connect residents to health care,” Scannell Bryan said.

Jiehuan Sun, Jyotsna Jagai, Dr. Robert Sargis, Maria Argos of UIC and Daniel Horton and Anastasia Montgomery from Northwestern University are co-authors on the paper.


Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573